These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 8959525

  • 1. Vaccination against Helicobacter pylori.
    Lee A.
    J Gastroenterol; 1996 Nov; 31 Suppl 9():69-74. PubMed ID: 8959525
    [Abstract] [Full Text] [Related]

  • 2. Prevention of Helicobacter pylori infection.
    Lee A.
    Scand J Gastroenterol Suppl; 1996 Nov; 215():11-5. PubMed ID: 8722377
    [Abstract] [Full Text] [Related]

  • 3. Mucosal immunization with a urease B DNA vaccine induces innate and cellular immune responses against Helicobacter pylori.
    Hatzifoti C, Roussel Y, Harris AG, Wren BW, Morrow JW, Bajaj-Elliott M.
    Helicobacter; 2006 Apr; 11(2):113-22. PubMed ID: 16579841
    [Abstract] [Full Text] [Related]

  • 4. Peroral immunization with Helicobacter pylori adhesin protein genetically linked to cholera toxin A2B subunits.
    Kim BO, Shin SS, Yoo YH, Pyo S.
    Clin Sci (Lond); 2001 Mar; 100(3):291-8. PubMed ID: 11222115
    [Abstract] [Full Text] [Related]

  • 5. Oral immunization of mice with lactic acid bacteria producing Helicobacter pylori urease B subunit partially protects against challenge with Helicobacter felis.
    Corthésy B, Boris S, Isler P, Grangette C, Mercenier A.
    J Infect Dis; 2005 Oct 15; 192(8):1441-9. PubMed ID: 16170763
    [Abstract] [Full Text] [Related]

  • 6. Oral immunization against Helicobacter pylori--a future concept.
    Michetti P.
    J Gastroenterol; 1998 Oct 15; 33 Suppl 10():66-8. PubMed ID: 9840022
    [Abstract] [Full Text] [Related]

  • 7. Development and evaluation of a DNA vaccine based on Helicobacter pylori urease B: failure to prevent experimental infection in the mouse model.
    Zavala-Spinetti L, Breslin MB, Correa H, Bégué RE.
    Helicobacter; 2006 Dec 15; 11(6):517-22. PubMed ID: 17083372
    [Abstract] [Full Text] [Related]

  • 8. [A vaccine against Helicobacter pylori infection].
    Presecki V, Katicić M, Kalenić S, Strnad M, Plecko V, Babus V, Dominis M.
    Lijec Vjesn; 2002 Sep 15; 124 Suppl 1():79-82. PubMed ID: 12592824
    [Abstract] [Full Text] [Related]

  • 9. The nontoxic CTA1-DD adjuvant enhances protective immunity against Helicobacter pylori infection following mucosal immunization.
    Akhiani AA, Stensson A, Schön K, Lycke N.
    Scand J Immunol; 2006 Feb 15; 63(2):97-105. PubMed ID: 16476008
    [Abstract] [Full Text] [Related]

  • 10. Effectiveness of vaccination with recombinant HpaA from Helicobacter pylori is influenced by host genetic background.
    Sutton P, Doidge C, Pinczower G, Wilson J, Harbour S, Swierczak A, Lee A.
    FEMS Immunol Med Microbiol; 2007 Jul 15; 50(2):213-9. PubMed ID: 17567282
    [Abstract] [Full Text] [Related]

  • 11. Oral vaccination with liposome-encapsulated recombinant fusion peptide of urease B epitope and cholera toxin B subunit affords prophylactic and therapeutic effects against H. pylori infection in BALB/c mice.
    Zhao W, Wu W, Xu X.
    Vaccine; 2007 Nov 01; 25(44):7664-73. PubMed ID: 17913305
    [Abstract] [Full Text] [Related]

  • 12. Development of a vaccine against Helicobacter pylori infection.
    Michetti P.
    Ital J Gastroenterol Hepatol; 1998 Oct 01; 30 Suppl 3():S339-41. PubMed ID: 10077770
    [Abstract] [Full Text] [Related]

  • 13. Helicobacter pylori vaccine development: optimisation of strategies and importance of challenging strain and animal model.
    Hoffelner H, Rieder G, Haas R.
    Int J Med Microbiol; 2008 Jan 01; 298(1-2):151-9. PubMed ID: 17714988
    [Abstract] [Full Text] [Related]

  • 14. Oral immunization with HpaA affords therapeutic protective immunity against H. pylori that is reflected by specific mucosal immune responses.
    Nyström J, Svennerholm AM.
    Vaccine; 2007 Mar 30; 25(14):2591-8. PubMed ID: 17239498
    [Abstract] [Full Text] [Related]

  • 15. Experimental model of Helicobacter pylori infection.
    Del Giudice G, Ghiara P, Rappuoli R.
    Ital J Gastroenterol Hepatol; 1998 Oct 30; 30 Suppl 3():S261-3. PubMed ID: 10077750
    [Abstract] [Full Text] [Related]

  • 16. Intranasal CpG-oligodeoxynucleotide is a potent adjuvant of vaccine against Helicobacter pylori, and T helper 1 type response and interferon-gamma correlate with the protection.
    Shi T, Liu WZ, Gao F, Shi GY, Xiao SD.
    Helicobacter; 2005 Feb 30; 10(1):71-9. PubMed ID: 15691317
    [Abstract] [Full Text] [Related]

  • 17. [Immunization with catalase and UreB two-valence vaccine for preventing Helicobacter pylori infection in mice].
    Lin HJ, Yang Q, Li J, Liu Y, Wang QY.
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Mar 30; 28(3):436-7. PubMed ID: 18359706
    [Abstract] [Full Text] [Related]

  • 18. Systemic immunization with unadjuvanted whole Helicobacter pylori protects mice against heterologous challenge.
    Harbour SN, Every AL, Edwards S, Sutton P.
    Helicobacter; 2008 Dec 30; 13(6):494-9. PubMed ID: 19166414
    [Abstract] [Full Text] [Related]

  • 19. Prophylactic and therapeutic efficacy of the epitope vaccine CTB-UA against Helicobacter pylori infection in a BALB/c mice model.
    Guo L, Liu K, Xu G, Li X, Tu J, Tang F, Xing Y, Xi T.
    Appl Microbiol Biotechnol; 2012 Sep 30; 95(6):1437-44. PubMed ID: 22569640
    [Abstract] [Full Text] [Related]

  • 20. Advances in vaccination against Helicobacter pylori.
    Velin D, Michetti P.
    Expert Rev Gastroenterol Hepatol; 2010 Apr 30; 4(2):157-66. PubMed ID: 20350263
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.